HSPB1 deficiency sensitizes melanoma cells to hyperthermia induced cell death

Hyperthermia has shown clinical potency as a single agent or as adjuvant to other therapies in cancer treatment. However, thermotolerance induced by thermosensitive genes such as the heat shock proteins can limit the efficacy of hyperthermic treatment. In the present study, we identified HSPB1 (HSP2...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, He-Xiao, Yang, Yang, Guo, Hao, Hou, Dian-Dong, Zheng, Song, Hong, Yu-Xiao, Cai, Yun-Fei, Huo, Wei, Qi, Rui-Qun, Zhang, Li, Chen, Hong-Duo, Gao, Xing-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341888/
https://www.ncbi.nlm.nih.gov/pubmed/27626679
http://dx.doi.org/10.18632/oncotarget.11894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341888/
https://www.ncbi.nlm.nih.gov/pubmed/27626679
http://dx.doi.org/10.18632/oncotarget.11894

Ejemplares similares